Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Cardiology
Gynecologic Cancers
Questions discussed in this category
Should all patients with a remote history of immunotherapy, chemotherapy and/or radiation therapy have a baseline TTE regardless of ASCVD risk?
2 Answers available
For patients on immune checkpoint inhibitors presenting with chest pain, dyspnea, fatigue, and troponin elevation, would you recommend early initiation of high dose steroids for empiric treatment of ICI myocarditis while pursuing workup with coronary angiogram, echocardiogram, and/or cardiac MRI, or wait until alternative etiologies have been ruled out?
2 Answers available
What is your surveillance approach for outpatient monitoring of ICI myocarditis?
(i.e. frequency of serial BNP, troponin, cMRI)
2 Answers available
Given recent studies investigating ICI myocarditis biomarkers such as Temra CD8+ cells, is there now a growing selection of clinical biomarkers, besides BNP and troponin, being measured routinely in ICI myocarditis cases?
2 Answers available
When would you consider tapering glucocorticoids in a patient with ICI-associated myocarditis?
2 Answers available
For a young patient with stage 4 endometrial cancer with an excellent response to anthracyclines, would you continue to give anthracyclines beyond the standard dosage cap if cardiac function remains normal by echocardiogram?
1 Answer available
16257
16315
13768
16253
15238
2116
Papers discussed in this category
Eur Heart J, 2022 Nov 01
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
JACC CardioOncol, 2022 Dec 20
Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions.
Eur Heart J, 2022 Jan 31
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
J Am Heart Assoc, 2020 Jan 21
Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment.
Circulation, 2020 Jun 15
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis.
Related Topics in Cardiology
Lung Cancer
Breast Cancer
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Gastrointestinal Cancers
Genitourinary Cancers
Pediatric Hematology/Oncology
Radiation Physics